The microglial cell, after many years of neglect, has become recognized as
the sole representative cell of the immune system that resides in the norma
l central nervous system. While normally dormant, microglia can be activate
d by secretory substances or signals associated with disease or injury, and
becomes a phagocytic cell, which also produces its own injurious molecules
. In the activating process, its morphology is changed from a resting proce
ss-bearing cell, into a rounded amoebic form, and displays new or increased
amounts of functional markers, such as receptors and Class I and Class II
MHC molecules. Microglia prepared from newborn mice or rats for tissue cult
ure are already activated, and can be used for studies of their phagocytic
properties. Although they can phagocytize foreign substances, their uptake
and metabolism of myelin are emphasized here, in keeping with their role in
demyelinating diseases. A number of receptors have been implicated and app
ear to be important in the attachment to, and ingestion of, myelin particle
s in vitro, including the Fc, complement, macrophage scavenger, and the Gal
ectin-3/MAC-2 receptors, although the alpha2-macroglobulin/low-density lipo
protein receptor and mannose receptors have also been suggested as particip
ants in myelin phagocytosis. Certain cytokines and adhesion molecules also
regulate the phagocytic activity of microglia. Comparative in vitro studies
of phagocytosis by peritoneal macrophages and microglia have shown that th
e two kinds of cells respond differently to regulatory molecules, and it is
concluded that they have different innate properties. The role of microgli
a in the demyelinative diseases experimental autoimmune encephalomyelitis a
nd multiple sclerosis is emphasized here, and the possible means of interve
ntion in the process leading to myelin destruction is discussed. (C) 2001 W
iley-Liss, Inc.